GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
98 hedge funds and large institutions have $798M invested in G1 Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less funds holding
Funds holding: 99 → 98 (-1)
94% less call options, than puts
Call options by funds: $248K | Put options by funds: $4.29M
Holders
98
Holding in Top 10
2
Calls
$248K
Puts
$4.29M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$6.01M | |
| 3 | +$5.89M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.89M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.96M |
Top Sellers
| 1 | -$27M | |
| 2 | -$7.2M | |
| 3 | -$3.14M | |
| 4 |
Morgan Stanley
New York
|
-$2.41M |
| 5 |
Goldman Sachs
New York
|
-$2.22M |